BioMarin to Participate in Citi's 13th Annual Biotech Conference on December 5 in New York City

 

SAN RAFAEL, Calif., /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that management will participate in Citi's 13th Annual Biotech Conference on December 5 in New York City.  To access the live webcast, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following each event.

BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical Inc.)

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts: 

 

Investors                                            

Media

Traci McCarty                                     

Debra Charlesworth

BioMarin Pharmaceutical Inc.              

BioMarin Pharmaceutical Inc.

(415) 455-7558                                     

(415) 455-7451

 

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-citis-13th-annual-biotech-conference-on-december-5-in-new-york-city-300758812.html

SOURCE BioMarin Pharmaceutical Inc.

 
 
Company Codes: NASDAQ-NMS:BMRN
 

Back to news